Skip to content

Author

T. Zininga

We have 3 of 54 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Phage Therapy and Phage-Derived Lytic Proteins in the One Health Era: Mechanisms, Challenges and Emerging Innovations

Antimicrobial resistance is a critical global health threat, as conventional antibiotics are increasingly ineffective against multidrug-resistant (MDR) pathogens, particularly ESKAPE organisms. In response, bacteriophages and their derived lytic proteins, including endolysins, holins, and spanins, have emerged as promi...

Moses Mwangi, Grace Gitau, F. Musila et al. · 0 citations
Open access Aug 2026

In silico identification of selective cyclodecapeptide inhibitors targeting Plasmodium falciparum Grp78 chaperone

This study sought to identify peptides that mimic the substrates of PfGrp78, which can be potential inhibitors of PfGrp78, and explored the mechanism of action of cyclodecapeptides, gramicidin S (GS) and tyrocidines (Trcs), which were previously shown to exhibit potent antimalarial activity.

Wendy Mthembu, A. Odugbemi, F. L. Muzenda et al. · 0 citations
#protein folding Review Open access Aug 2026

Exploiting ER proteostasis in malaria: protein disulphide isomerases as selective antimalarial targets.

PfPDI inhibitors are most likely to succeed as components of resistance-robust combination therapies, and progress will depend on structure-guided targeting of divergent non-catalytic surfaces, optimization of intracellular and ER exposure, and rigorous in-parasite target-engagement studies.

A. Odugbemi, Wendy Mthembu, Tawanda Zininga · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.